Results 151 to 160 of about 12,487 (241)

Next-generation inhibitors of SARS-CoV-2 M<sup>pro</sup> overcome the deficiencies of Paxlovid. [PDF]

open access: yesNat Commun
Luo G   +15 more
europepmc   +1 more source

Design and In Vitro Evaluation of Novel GC373-like SARS-CoV-2 Main Protease Inhibitors. [PDF]

open access: yesCurr Issues Mol Biol
Kuznetsova AA   +13 more
europepmc   +1 more source

Role of Structural Modifications in Peptidomimetic Compounds as Potential Antimicrobial Agents against <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i>: Balancing Bioavailability, Safety, and Antimicrobial Activity. [PDF]

open access: yesACS Omega
Dzierżyńska M   +11 more
europepmc   +1 more source

Novel macrocyclic peptidomimetics targeting the insulin-regulated aminopeptidase (IRAP): design, synthesis and evaluation. [PDF]

open access: yesRSC Med Chem
Olaniran Håkansson E   +9 more
europepmc   +1 more source

Peptidomimetic α,β-Unsaturated Ethyl Esters Are Irreversible Inactivators of Human Cathepsin L and Are Potent Inhibitors of SARS-CoV-2 in Cellular Models of COVID-19. [PDF]

open access: yesJ Med Chem
Kumar V   +11 more
europepmc   +1 more source

Machine Learning-Guided Repositioning of a SARS-CoV-2-Targeting Molecular Series as Cruzain Inhibitors. [PDF]

open access: yesChemMedChem
Lameiro RF   +10 more
europepmc   +1 more source

Structure-Guided SOCS3 Peptidomimetics: Design and Functional Characterization. [PDF]

open access: yesACS Omega
Cugudda A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy